BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28338707)

  • 21. Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
    Helleberg M; May MT; Ingle SM; Dabis F; Reiss P; Fätkenheuer G; Costagliola D; d'Arminio A; Cavassini M; Smith C; Justice AC; Gill J; Sterne JA; Obel N
    AIDS; 2015 Jan; 29(2):221-9. PubMed ID: 25426809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study.
    Nsanzimana S; Remera E; Kanters S; Chan K; Forrest JI; Ford N; Condo J; Binagwaho A; Mills EJ
    Lancet Glob Health; 2015 Mar; 3(3):e169-77. PubMed ID: 25701995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA).
    Reniers G; Slaymaker E; Nakiyingi-Miiro J; Nyamukapa C; Crampin AC; Herbst K; Urassa M; Otieno F; Gregson S; Sewe M; Michael D; Lutalo T; Hosegood V; Kasamba I; Price A; Nabukalu D; Mclean E; Zaba B;
    AIDS; 2014 Nov; 28 Suppl 4(4):S533-42. PubMed ID: 25406756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda.
    Mills EJ; Bakanda C; Birungi J; Chan K; Ford N; Cooper CL; Nachega JB; Dybul M; Hogg RS
    Ann Intern Med; 2011 Aug; 155(4):209-16. PubMed ID: 21768555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A reduction in adult blood stream infection and case fatality at a large African hospital following antiretroviral therapy roll-out.
    Feasey NA; Houston A; Mukaka M; Komrower D; Mwalukomo T; Tenthani L; Jahn A; Moore M; Peters RP; Gordon MA; Everett DB; French N; van Oosterhout JJ; Allain TJ; Heyderman RS
    PLoS One; 2014; 9(3):e92226. PubMed ID: 24643091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics and outcomes of older HIV-infected patients receiving antiretroviral therapy in Malawi: A retrospective observation cohort study.
    Tweya H; Feldacker C; Heller T; Gugsa S; Ng'ambi W; Nthala O; Kalulu M; Chiwoko J; Banda R; Makwinja A; Phiri S
    PLoS One; 2017; 12(7):e0180232. PubMed ID: 28686636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
    Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
    PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.
    Patterson S; Cescon A; Samji H; Chan K; Zhang W; Raboud J; Burchell AN; Cooper C; Klein MB; Rourke SB; Loutfy MR; Machouf N; Montaner JS; Tsoukas C; Hogg RS;
    BMC Infect Dis; 2015 Jul; 15():274. PubMed ID: 26183704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
    Johnson LF; May MT; Dorrington RE; Cornell M; Boulle A; Egger M; Davies MA
    PLoS Med; 2017 Dec; 14(12):e1002468. PubMed ID: 29232366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapy.
    Losina E; Schackman BR; Sadownik SN; Gebo KA; Walensky RP; Chiosi JJ; Weinstein MC; Hicks PL; Aaronson WH; Moore RD; Paltiel AD; Freedberg KA
    Clin Infect Dis; 2009 Nov; 49(10):1570-8. PubMed ID: 19845472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The population-level impact of public-sector antiretroviral therapy rollout on adult mortality in rural Malawi.
    Payne CF; Kohler HP
    Demogr Res; 2017; 36():1081-1108. PubMed ID: 29780281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
    Antiretroviral Therapy Cohort Collaboration
    Lancet; 2008 Jul; 372(9635):293-9. PubMed ID: 18657708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa.
    Floyd S; Marston M; Baisley K; Wringe A; Herbst K; Chihana M; Kasamba I; Bärnighausen T; Urassa M; French N; Todd J; Zaba B
    Trop Med Int Health; 2012 Aug; 17(8):e84-93. PubMed ID: 22943383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of 90-90-90 on HIV-1 incidence and mortality in eSwatini: a mathematical modelling study.
    Akullian A; Morrison M; Garnett GP; Mnisi Z; Lukhele N; Bridenbecker D; Bershteyn A
    Lancet HIV; 2020 May; 7(5):e348-e358. PubMed ID: 32061317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twelve-year mortality in adults initiating antiretroviral therapy in South Africa.
    Cornell M; Johnson LF; Wood R; Tanser F; Fox MP; Prozesky H; Schomaker M; Egger M; Davies MA; Boulle A;
    J Int AIDS Soc; 2017 Sep; 20(1):21902. PubMed ID: 28953328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coming home to die? The association between migration and mortality in rural Tanzania before and after ART scale-up.
    Levira F; Todd J; Masanja H
    Glob Health Action; 2014; 7():22956. PubMed ID: 24857612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
    Lima VD; Hogg RS; Harrigan PR; Moore D; Yip B; Wood E; Montaner JS
    AIDS; 2007 Mar; 21(6):685-92. PubMed ID: 17413689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender differences in retention and survival on antiretroviral therapy of HIV-1 infected adults in Malawi.
    Taylor-Smith K; Tweya H; Harries A; Schoutene E; Jahn A
    Malawi Med J; 2010 Jun; 22(2):49-56. PubMed ID: 21614882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of mortality in adult people living with HIV on antiretroviral therapy in Nepal: A retrospective cohort study, 2004-2013.
    Angdembe MR; Rai A; Bam K; Pandey SR
    PLoS One; 2019; 14(4):e0215776. PubMed ID: 31013320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.